CLINICAL_TRIALS
trial_result
· 2016-10-10
Clinical Trial Update: Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection [Phase 3]
Summary
A Phase 3 clinical trial evaluating pelubiprofen and loxoprofen for acute upper respiratory infection has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Acute Upper Respiratory Infection, Fever | Phase 3 | Status: COMPLETED